English | Español

Abbvie
Press release submission | Jul 24, 2021

DALVANCE® (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric Patients

Press release submission | Aug 15, 2020

ABBVIE: New England Journal of Medicine Publishes Positive Phase 3 Data of Venetoclax Combination in Acute Myeloid Leukemia (AML) Patients
Press release submission | Nov 26, 2018

ABBVIE: Receives US FDA Accelerated Approval for VENCLEXTA® (venetoclax) for Treatment of Newly-Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy
Press release submission | Sep 23, 2018

ABBVIE: Announces $5 Million Donation to Family Reach to Support Children Battling Cancer and Their Families
Carrie Bradon | Nov 28, 2017

AbbVie to take part in Evercore ISI Biopharma Catalyst conference
Kathy Adams | Nov 15, 2017

AbbVie executive to present at Jefferies London Healthcare Conference
Robert Hadley | Nov 7, 2017

FDA fast-tracking review for AbbVie’s endometriosis drug
Mark Iandolo | Nov 1, 2017

AbbVie to present abstracts on its investigational immunology medicine portfolio

Trending
+ Community
Patient Daily | Mar 27, 2025

Healthcare professionals recognized at National Breathe Free conference for outstanding dedication
+ Regulatory
Patient Daily News Service | Mar 28, 2025

Former HHS Official: '340B program is just one of many reminders of the abuse and waste' in D.C.
+ Pharmaceuticals
Patient Daily | Mar 31, 2025

Founder of RXSaveCard on drug pricing: 'We typically see savings of $6,000+ per prescription'
+ Pharmaceuticals
Patient Daily | Apr 1, 2025

American Lung Association responds to HHS budget cuts